Doriano Lamba

Title: Doriano Lamba: Innovator in Humanized Antibodies

Introduction

Doriano Lamba is a notable inventor based in Rome, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 3 patents to his name, Lamba's work focuses on innovative methods for treating pain and enhancing antibody efficacy.

Latest Patents

Lamba's latest patents include groundbreaking work on polynucleotides encoding humanized anti-NGF antibodies. This patent details a method for the humanization of the VH and VL variable regions of an animal antibody of known sequence. It specifically addresses the creation of humanized animal antibodies, particularly anti-NGF and anti-TrkA humanized animal antibodies. Another significant patent outlines a method for the treatment of pain using humanized anti-nerve growth factor antibodies, again focusing on the humanization of the VH and VL variable regions.

Career Highlights

Throughout his career, Doriano Lamba has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Abbott Research B.V. and AbbVie Inc. His work in these organizations has contributed to advancements in therapeutic antibody development.

Collaborations

Lamba has collaborated with esteemed colleagues in his field, including Antonino Cattaneo and Sonia Covaceuszach. These partnerships have fostered innovation and have been instrumental in the progress of his research.

Conclusion

Doriano Lamba's contributions to the field of humanized antibodies are noteworthy. His innovative patents and collaborations highlight his commitment to advancing biotechnology. His work continues to impact the treatment of pain and the development of effective therapeutic antibodies.